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Abstract
This study aimed to investigate the effects of nonsurgical periodontal therapy on white blood cell (WBC) count and levels of transforming growth factor beta (TGF-β) 
in serum from subjects with severe periodontitis. Serum from 28 subjects with periodontitis (mean age: 34.36±6.24; 32% men) and 27 healthy controls (mean age: 
33.18±6.42; 33% men) were collected prior to therapy. Blood samples were obtained from 23 subjects who completed therapy (9-12 months). A well-controlled 
periodontal treatment protocol was established in three stages: mechanical periodontal therapy (scaling and root planning), reinstrumentation of dental sites, and sup-
portive periodontal therapy. Periodontal and systemic parameters such as the total number of WBCs and TGF-β levels, accessed by enzyme-linked immunosorbent 
assay (ELISA), were included. After therapy, all clinical periodontal parameters decreased (p<0.0001). There were no statistical differences in WBC count between 
experimental and control groups before or after therapy. However, after therapy, the mean value of lymphocytes in patients with localized aggressive periodontitis 
(LAgP) was statistically higher than that of patients with generalized chronic periodontitis (GCP) (p<0.0357). Additionally, TGF-β levels in LAgP and GCP patients 
were higher compared to controls before therapy (p<0.05 and p<0.01, respectively). In LAgP patients, periodontal therapy was associated with increased number of 
lymphocytes.
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Introduction
Periodontal diseases are characterized as the patho-
logical manifestation of the host immune response to the 
bacterial infection at the tooth/gingival interface. These 
are mainly caused by Gram-negative bacteria, including 
Porphyromonas gingivalis (Pg), Prevotella intermedia, 
Aggregatibacter actinomycetemcomitans (Aa), and Tan-
nerella forsythia. Individual response variations can be 
explained by a combination of factors that confer upon 
them a complex nature. Among these factors, suscepti-
bility becomes prominent, with special attribution given 
to genetic polymorphisms, environmental factors and 
pathogen virulence factors (1, 2). Individuals affected 
by the disease share common polymorphisms in speci-
fic genes that are important for the regulation of the in-
flammatory response (3, 4). However, the determinants 
for the susceptibilty of periodontitis are not well defined 
(5).
Severe periodontitis affects up to 15% of most popu-
lations (6). In Brazil, the most recent National Survey 
of Oral Health reported that the distribution of the most 
severe forms of periodontal disease is more significant 
in adults between 35-44 years of age, with a prevalence 
of 19.4% (7).
The term periodontitis generically comprises of 
chronic forms of periodontal disease, which is the result 
of a polymicrobial infection and is characterized by the 
loss of collagen fibers and insertion in the cementum 
surface (mineralized tissue that covers the root surface), 
apical migration of junctional epithelium (epithelium 
continuous with the oral epithelium that promotes the 
insertion of the gum to the tooth), periodontal pocket 
formation (cementum surface devoid of periodontal 
fibers) and alveolar bone reabsorption. Such damage 
compromises the function of the periodontal tissues and 
may result in tooth loss (1).
More than 700 bacterial species can occupy perio-
dontial pockets (8), and a combination of aerobic and 
anaerobic microbiota is typically seen in infection. Sub-
stantial tissue destruction in patients with severe peri-
odontitis is characterized, in many cases, by the pres-
ence of deep periodontal pockets around many or all 
the teeth. The aggregated epithelial lesions equal in size 
to an ulcerated wound with an area of 8 to 20 cm2, in 
accordance with clinical estimations (9). However, the 
disease can remain asymptomatic for decades, during 
which time its detection is performed only by clinical 
examination with periodontal probe and/or intraoral x-
rays (9). Thus, the chronic and cyclical nature of peri-
odontal disease provides an opportunity for continuous 
hematogenous dissemination of periodontal pathogens, 
bacterial antigens and inflammatory mediators (5, 10).
Since the beginning of the 1990s, evidence has 
pointed to periodontitis as a risk factor for systemic 
conditions, such as cardiovascular disease (CVD), ad-
verse outcomes of pregnancy, diabetes and lung disea-
se (11). Recently, a review of the evidence on associa-
tions between periodontitis and systemic diseases and 
conditions, particularly respiratory disease, chronic 
kidney disease, rheumatoid arthritis, cognitive impair-
ment, obesity, metabolic syndrome and cancer was also 
published. There was strong evidence that improving 
oral hygiene has positive effects on the prevention of 
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nosocomial pneumonia. The published evidence sup-
ports modest correlations between periodontitis and 
chronic kidney disease and obesity and weak correla-
tions between periodontitis and cognitive impairment, 
rheumatoid arthritis and metabolic syndrome (5). In this 
context, the increase in the number of white blood cells 
(WBC) is associated with the increased risk of coronary 
heart disease, CVD, atherosclerosis, thrombosis and 
myocardial ischemia. This increase may be caused by 
the inflammatory nature of chronic infections such as 
periodontitis (12).
The T cells CD4+ CD25+ that express transcription 
factor Foxp3 are regulatory T cells (Tregs) that prevent 
the overreactive adaptive immune response and may be 
associated with periodontal disease and its alleviation. 
These specifically regulate the activation, proliferation 
and effector function of activated T cells and the res-
toration of homeostasis after infection (13). In the pre-
sence of Tregs, a reduction in the levels of interferon 
gamma (IFN-γ), interleukin (IL) -17, tumor necrosis 
factor (TNF) and IL-1β is observed at murine and ca-
nine periodontal disease sites (14). Cytokines produced 
by Tregs are IL-10, transforming growth factor beta 
(TGF-β) and cytotoxic T-lymphocyte-associated protein 
4 (CTLA-4), which, in general, subregulate inflamma-
tion. IL-10, TGF-β1 and CTLA-4 are reported to slow 
the progression of periodontal disease (5). In addition to 
the protective role in periodontal tissue damage, Tregs 
also play an important role in immune tolerance (15). 
Also, TGF-β has been studied as a form of treatment 
in the context of the healing and regeneration of perio-
dontal bone (14). For example, Tregs negatively mo-
dulates proinflammatory cytokines responsible for the 
inhibition of various processes during the regeneration 
of tissue.
Nonsurgical periodontal therapy acts to reduce in-
flammation markers in the blood (C-reactive protein 
[CRP], IL-6, etc.) and reveals some important aspects 
of the systemic reach of periodontal inflammation (4, 
15-17). Thus, based on the concept of the resolution of 
disease, it was established in this study that periodontal 
therapy would be considered complete only after con-
firming the remission of clinical signs of inflammation 
such as the absence of bleeding on probing (BOP) and 
residual periodontal pockets. However, it is emphasized 
that the mechanical removal of the biofilm by scaling 
and root planning, with or without another supporting 
modality, does not mean that, at any magnitude, inflam-
mation / infection does not persist. Sometimes the re-
moval of local factors is only achieved after repeated 
specific actuations principally at sites in which there still 
exist clinical signs of inflammation. Sites with residual 
periodontal pockets that continue bleeding on probing 
undoubtedly require new instrumentation (scaling and 
root planning) and reinforcement of oral hygiene in-
struction. Moreover, the need for reinstrumentation and 
clinical response are unique to each individual patient 
and for this reason, there is no way to generically es-
tablish the completion of therapy for all patients at the 
same time.
The goal of this study was to investigate the effects of 
severe periodontitis as well as the contributions of non-
surgical periodontal therapy on the systemic inflamma-
tory response regarding the serum levels of TGF-β and 
WBC count. Furthermore, the relationship between the 
number of lymphocytes, serum levels of TGF-β, and 
subgroups of severe periodontal disease (generalized 
aggressive periodontitis [GAgP], localized aggressive 
periodontitis [LAgP] and generalized chronic perio-
dontitis [GCP]) was explored. For this, the individual 
response of each patient to therapy was considered, in 
respect to the time needed to resolve inflammation in 
each individual and, from this, the establishment of su-
pportive periodontal therapy (SPT), also known as pe-
riodontal maintenance.
Materials and methods
Subjects and study groups
The study protocol was approved by the Ethics Com-
mittee of the Faculty of Health Sciences - University of 
Brasília, Brazil (045/2008). All subjects were informed 
about the purpose of the study, both orally and written, 
and an informed consent document prior to participa-
tion was also signed. The clinical trial was registered at 
http://www.clinicaltrials.gov.br/, No. RBR-24T799.
The total sample (convenience sampling) consisted 
of 55 systemically healthy subjects. The periodontitis 
group (PG) consisted of 19 women (68%) and nine men 
(age range 20-45; mean age: 34.36±6.24), with ≥18 
teeth. The classification of periodontal disease was ac-
cording to Armitage and Cullinan (18). Chronic perio-
dontitis (CP), with a higher prevalence in adults, can 
also occur in children and adolescents. In this, there is 
correlation between the severity of bone destruction and 
quantity of dental biofilm and calculus, in addition to 
the moderate growth rate in the majority of cases. CP is 
classified as localized when less than 30% of dental si-
tes (mesiobuccal, buccal, distobuccal, mesiolingual, lin-
gual and distolingual) are affected, and as generalized 
(GCP) when it exceeds this limit. LAgP is characterized 
by the destruction of the periodontal tissues located in 
the first molar / incisor with interproximal insertion loss 
in at least two permanent teeth, one of which is the first 
molar, and involving no more than two teeth beyond 
the first molars and incisors. This is normally detected 
and diagnosed during puberty in systemically healthy 
individuals. The GAgP usually affects individuals un-
der age 30, but can affect older individuals. The loss of 
interproximal insertion is characterized as generalized 
when it affects at least three permanent teeth, in addition 
to the first molars and incisors. In addition, the AgP is 
characterized by a rapid loss of clinical attachment and 
alveolar bone.
The control group (CG) consisted of 18 women (67%) 
and nine men (age range 21-44; mean age: 33.18±6.42) 
with clinical probing depth (PD) ≤3mm and clinical at-
tachment level (CAL) ≤ 3mm, ≤ 10% of sites with BOP, 
and no radiographic evidence of bone loss (Figure 1). 
Exclusion criteria were history of smoking, pregnancy 
or lactation, periodontal therapy, antimicrobial therapy 
for systemic conditions or use of topical oral antibiot-
ics in the last twelve months, diabetes, autoimmune dis-
ease, acute infections, severe allergies, gastrointestinal 
and renal diseases, cancer, morbid obesity (body mass 
index [BMI] >40kg/m2) or underweight (malnourished 
BMI <18.5kg/m2) (19), and use of medications that alter 
the levels of inflammatory mediators.
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EDTA tube was analyzed within three hours in order to 
perform blood counts with standard measurements for 
the number of neutrophils, lymphocytes, monocytes, 
basophils and eosinophils. Plasma and serum samples 
were immediately placed on ice and stored at -80°C.
Serum levels of TGF-β were detected by enzyme-
linked immunosorbent assay (ELISA) according to the 
manufacturer’s instructions (R&D Systems). Briefly, 
96-well plates were coated with anti-human TGF-β. 
After blocking for 2 h to avoid non-specific binding, 
the standard cytokine provided with the kit or serum 
samples were inserted. The cytokine was detected by 
horseradish peroxidase-labeled monoclonal antibody 
specific to the target after anti-human biotinylated an-
tibodies were placed in each well and incubated for 2 h 
at room temperature. The microplate was washed to re-
move unbound enzyme-labeled antibodies. The amount 
of horseradish peroxidase bound to each well was deter-
mined by the addition of a substrate solution. The reac-
tion was stopped by the addition of 1 M sulfuric acid, 
and the plates were read at 492 nm in a microplate read-
er (Thermo Scientific). The concentrations of TGF-β in 
each sample were determined by interpolation from a 
standard curve and presented as picograms per milliliter 
(± standard deviation). Serum levels of IL-6 were also 
investigated but were non-detectable in the samples.
Statistical analysis
The clinical periodontal parameters PI, PD (≤3, 5 
and 6mm) and BOP prior to and post-therapy in the 
PG were compared by paired Student’s t-test, as well 
as lymphocytes, monocytes, neutrophils and total white 
blood cells. In both periods evaluated for this group, a 
nonparametric Wilcoxon test was used for the following 
variables: number of teeth (NT), PD = 4 and ≥7 mm, 
eosinophils and basophils. The measurements NT, PI, 
BOP and hematological characteristics were compared 
between both groups before and after therapy by Stu-
dent’s t-test for variables that showed the Gaussian dis-
tribution. In cases where normality was not observed 
for both groups, the nonparametric Mann-Whitney test 
was used. Data were analyzed by SAS 9.2 for Windows. 
For purposes of analysis, a significance level of 5% was 
used (p<0.05).
To avoid interference of periodontal disease clas-
sification in the interpretation of the results, compari-
sons of the mean values of the variables studied in 
post-treatment between the three types of periodonti-
tis (GCP, GAgP, LAgP) from the periodontitis group 
were made. Thus, comparisons of all tested measures 
cited above were made using the analysis of covariance 
model (ANCOVA). The value of the measurement after 
therapy was considered as the dependent variable and 
the value of the measurement at baseline was the auxil-
iary variable. Tukey’s adjustment was used to adjust for 
three multiple comparisons and pre-specified contrasts 
were used to test three hypotheses: first, the mean val-
ues in GAgP subgroup do not significantly differ from 
the mean values in LAgP subgroup; second, the mean 
values in GAgP subgroup do not significantly differ 
from the mean values in the GCP subgroup; and third, 
the mean values in LAgP subgroup do not significantly 
differ from the mean values in the GCP subgroup. For 
the age variable, comparisons were made of the mean 
Clinical examination
The clinical examination performed at baseline and 
after six months of SPT included detection of visible 
plaque accumulation described as plaque index (PI) 
(20), BOP (20), PD and CAL. Measurements were as-
sessed at four sites around each tooth, buccal, lingual 
and both proximal sites using a manual probe (probe 
Michigan O with Williams markings) excluding third 
molars. Clinical examination was performed by a single 
experienced examiner. The calibration and measure-
ments for PD and CAL were repeated within 24 h and 
demonstrated a concordance rate above 80%. The BOP 
was calculated by Kappa coefficient and the intra-exam-
iner agreement was > 0.85.
Treatment protocol and laboratory analysis
PG subjects were treated in three stages: mechani-
cal periodontal therapy (scaling and root planning) with 
Gracey curettes (5/6, 7/8, 11/12, 13/14), reinstrumenta-
tion of sites and SPT. The first stage was carried out in 
≤14 days. One month later, in stage 2, new mechanical 
instrumentation was performed in patients who persist-
ed with deep pockets, BOP and calculus. At this stage, 
meticulous scaling and root planning were performed 
until the following periodontal conditions were reached: 
PD greater than 4mm in at least three or fewer sites, PD 
greater than 5mm in two places at most, PI ≤ 15% and 
BOP ≤ 10%. In Stage 3, subjects were scheduled bi-
weekly or monthly, according to the need to control bio-
film formation. SPT was performed for six months. CG 
subjects received oral hygiene instruction at baseline.
Out of the 28 subjects in the PG (14 patients diag-
nosed with GCP; 8 GAgP patients; 6 LAgP patients), 
five did not complete the treatment. Twenty-three com-
pleted the three stages of periodontal protocol (12 GCP 
patients, 5 GAgP patients and 6 LAgP patients). Among 
these, ten subjects (43%) completed the treatment in 
nine months, ten subjects (43%) in ten months, and 
three subjects (14%) in 12 months.
Blood samples were collected for biochemical anal-
ysis at baseline for all 28 PG subjects and 27 CG sub-
jects. Subsequent blood samples were collected from 23 
PG subjects who completed treatment in their respec-
tive time periods after the beginning of treatment: 9 
months (ten individuals), 10 months (ten individuals) 
and twelve months (three individuals). Blood was col-
lected in gel separator tubes between 7 and 8 h. Each 
Figure 1. Study design. GCP - generalized chronic periodontitis; 
GAgP - generalized aggressive periodontitis; LAgP - localized ag-
gressive periodontitis.
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are shown in Table 1.
In the PG, nonsurgical periodontal therapy led to a 
significant decrease in all clinical periodontal param-
eters (p<0.0001). At baseline, the CG was significantly 
different from the PG for PI and BOP (p<0.0001). The 
mean values for PI and BOP in the PG were greatly re-
duced after the therapy.
As shown in Table 2, there were no statistical differ-
ences in hematological parameters between the PG and 
the CG before or after therapy. In addition, these pa-
rameters for the PG were not modified after nonsurgical 
periodontal therapy.
Among the 23 individuals who completed treat-
ment, 12 presented GCP (8 women and 4 men; mean 
age: 37.17±1.63), five, GAgP (4 women and 1 man; 
mean age: 31.60±2.53) and six LAgP (4 women and 2 
men; mean age: 30.67±2.31). The values for the age, as 
well as the proportion of males and females in the PG 
after therapy did not differ among the three periodon-
titis subgroups (p=0.553 and p=0.8485, respectively). 
Since the PG in this study consisted of three subgroups 
of severe periodontitis, comparisons were made of the 
mean values post-treatment between these subgroups 
for the above-mentioned measures (Tables 3 and 4). 
It was observed that except for lymphocytes cells, the 
values after therapy among the three groups using the 
analysis of variance model (ANOVA). Tukey’s adjust-
ment was used to adjust for three multiple comparisons, 
and pre-specified contrasts were used to test the same 
above-mentioned three hypotheses. A comparison of the 
proportion of males, as well as females, between groups 
was tested using the chi-square test.
Finally, serological data, pre- and post-therapy, in 
reference to the quantification of TGF-β by ELISA were 
analyzed by ANOVA following a criterion of Tukey’s 
post-test in GraphPad Prism (v5.0). For purposes of 
analysis, a significance level of 5% was used (p<0.05).
Results
Demographic, hematological characteristics and clin-
ical oral parameters of the study population, before 
and after nonsurgical periodontal therapy
Initially, 28 patients with periodontitis were involved 
in this study (32% men; mean age: 34.36±6.24) and 27 
healthy controls (33% men; mean age: 33.18±6.42). 
There was no difference between PG and CG for age 
(p=0.4955) and gender (p=0.9251). Of all the patients in 
the PG, 23 were followed until remission of periodontal 
disease. Clinical oral parameters prior to and post-SPT 
Parameters* Control(n=27)
Pre-therapy
(n=28)
Post-therapy 
(n=23)
p value
pre x post
p value
control x pre
p value
control x post
NT 28.78±2.01 27.25±4.84 24.70±5.79 0.00011 0.53173 0.02943
PI (%) 4.74±2.30 63.61±33.64 4.83±6.73 <0.00012 <0.00013 0.06793
BOP (%) 2.67±1.49 44.46±29.35 1.63±3.35 <0.00012 <0.00013 <0.00013
PD (mm)
≤3 mm 100.00±0.00 68.71±14.38 98.32±1.79 <0.00012 NA NA
4 mm 0.00±0.00 4.02±4.02 0.63±0.96 <0.00011 NA NA
5-6 mm 0.00±0.00 17.08±8.85 0.85±1.22 <0.00012 NA NA
≥7 mm 0.00±0.00 10.45±8.89 0.17±0.61 <0.00011 NA NA
CAL (mm)
≤3 mm 100.00±0.00 62.56±18.20 NA NA NA NA
4 mm 0.00±0.00 4.97±4.77 NA NA NA NA
5-6 mm 0.00±0.00 18.74±8.96 NA NA NA NA
≥7 mm 0.00±0.00 13.73±11.49 NA NA NA NA
Table 1. Clinical oral parameters before and after supportive periodontal therapy.
*Results shown as mean ± standard deviation (SD).
1Wilcoxon test; 2pair T test; 3Mann-Whitney test; NA – not apllicable.
NT - number of teeth, PI - plaque index, BOP - bleeding on probing, PD - probing depth, CAL - clinical attachment level.
Table 2. Hematologic parameters before and after supportive periodontal therapy.
Parameters* Control(n=27)
Pre-therapy
(n=28)
Post-therapy 
(n=23)
p value
pre x 
post
p value
control x 
pre
p value
control x 
post
Eosinophils (mm3) 
references 45 a 400 143.74±102.00 227.96±179.80 178.26±95.26 0.1666
1 0.05493 0.25483
Basophils (mm3) 
references 0 a 100 14.19±31.35 8.71±21.97 13.30±21.30 0.2188
1 0.57653 0.60333
Lymphocytes (mm3) 
references 900 a 3300 2238.52±520.45 2136.75±508.12 2075.22±550.65 0.3018
2 0.46634 0.28704
Monocytes (mm3) 
references 90 a 800 428.22±141.26 368.75±128.59 366.65±138.50 0.5187
2 0.10824 0.12774
Neutrophils (mm3) 
references 2295 a 6500 3208.56±865.86 3548.64±1279.78 3104.59±1496.55 0.0871
2 0.32794 0.80494
Total Leukocytes (mm3) 
references 4500 a 10000 6171.48±1260.51 6297.50±1515.88 5970.00±1734.72 0.1808
2 0.73934 0.63734
*Results shown as mean ± standard deviation (SD).
1Wilcoxon test; 2pair T test; 3Mann-Whitney test; 4T test.
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Discussion
In individuals susceptible to periodontitis, unnatural 
resolution of periodontal inflammation results in chron-
ic inflammation, which may have a systemic impact (5, 
21-25). The acute inflammatory response is protective, 
but a failure to remove the inflammatory cells, espe-
cially neutrophils, characterize chronic, pathological 
and destructive lesions (5). Therefore, it is evident that 
the three aspects of the pathogenesis of periodontitis 
(infection, inflammation and adaptive immunity) have 
a potential role and impact on the systemic immunoin-
flammatory response, which either initiate or mediate a 
wide range of systemic diseases (5).
In a previous study by our group, we found levels of 
high-sensitivity C-reactive protein (hs-CRP) > 0.3 mg/
dL in individuals with severe periodontitis compared to 
controls (60.87 versus 23.08, respectively; p=0.0216) 
(7) and periodontal therapy was associated with a de-
crease in hs-CRP levels circulating in serum and an 
increase in high density lipoprotein.
This study investigated the WBC count in peripheral 
mean values did not significantly differ among the three 
subgroups of severe periodontitis (GCP; GAgP; LAgP). 
However, the mean value corresponding to the lympho-
cyte cells in the LAgP subgroup was statistically higher 
than the mean value in the GCP subgroup (p<0.0357), 
with no statistically significant difference between the 
other subgroups. The mean values for lymphocyte cells 
in three subgroups, in descending order, were LAgP > 
GCP > GAgP.
ELISA before and after nonsurgical periodontal the-
rapy
In the PG, samples of the disease groups (LAgP, 
GAgP, GCP) showed a higher amount of TGF-β before 
nonsurgical periodontal therapy, however, there was no 
significant difference when the TGF-β levels were com-
pared before and after therapy for all groups (Figure 2). 
In addition, TGF-β levels were significantly higher in 
patients with LAgP (p<0.05) and GCP (p<0.01) com-
pared to controls prior to nonsurgical periodontal the-
rapy. IL-6 was not detectable in any disease group and 
analyzed time.
Table 3. Clinical oral parameters before and after supportive periodontal therapy in periodontitis subgroups.
periodontitis subgroups* p value
Variables GAgP LAgP GCP
Comparison 
between 
subgroups – 
F test†
GAgP 
vs 
LAgP§
GAgP 
vs 
GCP§
LAgP 
vs 
GCP§
NT 22.81 ± 1.09 24.79 ± 1.01 25.43 ± 0.72 0.1722 0.3736 0.1551 0.8729
PI (%) 9.71 ± 2.18 3.26 ± 2.02 3.57 ± 1.41 0.0624 0.1035 0.0701 0.9916
BOP (%) 3.22 ± 1.26 1.61 ± 1.16 0.98 ± 0.77 0.3304 0.6541 0.3012 0.8946
PD (mm)
≤3 mm 98.16 ± 0.77 98.66 ± 0.75 98.21 ± 0.47 0.8742 0.9029 0.9984 0.8702
4 mm 0.89 ± 0.45 0.43 ± 0.42 0.63 ± 0.29 0.7568 0.7364 0.8791 0.9204
5-6 mm 1.63 ± 0.54 0.07 ± 0.53 0.91 ± 0.35 0.1719 0.1480 0.5138 0.4220
≥7 mm 0.06 ± 0.30 -0.05 ± 0.27 0.33 ± 0.18 0.4406 0.9664 0.7131 0.4794
* Values plus or minus are the adjusted mean ± standard error.
† p-values calculated using ANCOVA; § p-values between subgroups calculated using ANCOVA. Multiple comparisons were adjusted by 
Tukey's test.
GAgP - generalized aggressive periodontitis, LAgP - localized aggressive periodontitis, GCP - generalized chronic periodontitis.
NT - number of teeth, PI - plaque index, BOP - bleeding on probing, PD - probing depth.
Table 4. Hematologic parameters before and after supportive periodontal therapy in periodontitis subgroups.
* Values plus or minus are the adjusted mean ± standard error.
† p-values calculated using ANCOVA; § p-values between subgroups calculated using ANCOVA. Multiple comparisons were adjusted by Tukey's 
test.
GAgP - generalized aggressive periodontitis, LAgP - localized aggressive periodontitis, GCP - generalized chronic periodontitis.
periodontitis subgroups* p value
Variables GAgP LAgP GCP
Comparison 
between 
subgroups – F 
test†
GAgP 
vs 
LAgP§
GAgP 
vs GCP§
LAgP vs 
GCP§
Eosinophils (mm3) 
references 45 a 400 143.65 ± 41.92 214.29 ± 38.38 174.67 ± 27.30 0.4625 0.4374 0.8143 0.6887
Basophils (mm3) 
references 0 a 100 16.62 ± 8.64 10.92 ± 7.92 13.11 ± 5.68 0.8840 0.8741 0.9411 0.9740
Lymphocytes (mm3) 
references 900 a 3300 1939.53 ± 153.83 2397.50 ± 132.14 1970.61 ± 89.95 0.0372 0.1100 0.9840 0.0357
Monocytes (mm3) 
references 90 a 800 384.91 ± 57.47 353.58 ± 54.42 365.58 ± 36.34 0.9282 0.9234 0.9556 0.9823
Neutrophils (mm3) 
references 2295 a 6500 3397.12 ± 903.39 2890.54 ± 542.42 3153.11 ± 391.02 0.8672 0.8785 0.9684 0.9205
Total Leukocytes (mm3) 
references 4500 a 10000 6028.84 ± 628.26 6124.48 ± 593.06 5868.24 ± 411.66 0.9360 0.9933 0.9751 0.9357
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The number of eosinophils, basophils, lymphocytes, 
monocytes, neutrophils and total leukocytes found in 
patients with severe periodontitis in this study (Table 2) 
did not set any leukocytosis frame, indicating that sys-
temic inflammation raised by periodontal infection was 
not well pronounced. This also suggests that in general, 
participants in the study were systemically healthy, and 
nonsurgical periodontal therapy produced no change in 
leukocyte differential counts.
These data confirmed the results of earlier studies 
(35, 36) showing that peripheral blood mononuclear 
cells from patients with periodontitis did not proliferate 
in response to bacterial antigens. However, other studies 
(37, submitted paper in J. Investig. Clin. Dent. 2014, 
Oct 6) have confirmed an increased number of WBCs 
and neutrophils in the peripheral blood of patients with 
moderate to severe periodontitis, with a positive corre-
lation between disease severity and number of WBCs 
in the blood. It was recently demonstrated a significant 
increase in the number of neutrophils in the peripheral 
blood of patients with GAgP (submitted paper in J. In-
vestig. Clin. Dent. 2014, Oct 6). In the present study, af-
ter nonsurgical periodontal therapy, the number of lym-
phocytes in patients with LAgP was statistically higher 
than patients with GCP (p <0.0357) (Table 4). Among 
the other subgroups (GAgP versus LAgP and GAgP 
versus GCP) there was no statistically significant dif-
ference (Table 4). The lymphocyte numbers in the three 
subgroups were, in descending order, LAgP > GCP > 
GAgP, similar to that reported by a previous study (38). 
These authors compared the composition of gingival 
lesions of 21 patients with CP and six LAgP children. 
Reviews of the stereological and histochemical analy-
sis showed that lymphocytes and B cells, in particular, 
occupied fractions of volume significantly greater in 
the LAgP than in the CP. Also, Cairo et al. (2010) (31) 
found a strong antibody response in the serum for infec-
tious agents in LAgP and poor antibody response in the 
serum for GAgP.
As for the effects of nonsurgical periodontal therapy 
on clinical periodontal parameters, a significant decre-
ase became clear in all of them (p <0.0001) (Table 1). 
It should be noted that there was a significant reduc-
tion of PI from 63.61±33.64 to 4.83±6.73 and of BOP 
from 44.46±29.35 to 1.63±3.35. After therapy, the NT 
was statistically fewer due to the extraction of periodon-
tally condemned teeth (p =0.0001) (Table 1). This set 
of measures relating to active periodontal therapy and 
SPT ensured adequate clinical response to all patients. 
Furthermore, such conduct allowed for a more accurate 
verification of the effects of therapy on TGF-β levels 
and WBC count and thus confirm the role of severe pe-
riodontitis in systemic inflammation.
Additionally, rigorous therapeutic protocols and pe-
riodontal maintenance contributed to the restoration of 
phagocytic function in peripheral blood neutrophils (39) 
and reduction of hs-CRP levels in patients with severe 
periodontitis (7). These findings also support the con-
clusions of D’Aiuto et al. (2004) (16, 17) and Kamil et 
al. (2011) (40) when reporting a greater reduction in the 
levels of systemic inflammatory markers among those 
with better clinical responses to periodontal therapy.
It should be noted that an interpretation of the re-
sults of related studies becomes difficult due to some 
blood and TGF-β levels in the three severe periodontitis 
groups (GAgP, LAgP e GCP) as well as the effects of 
nonsurgical periodontal therapy on them. It was noted 
that the chronic lesions of human periodontal disease 
showed an increased expression of regulatory cytokines 
such as TGF-β (26). Although Tregs and Th17 cells per-
form different roles in the pathogenesis of infection, it 
has been shown that there is a reciprocal path of de-
velopment. Naive T cells exposed to TGF-β upregulate 
Foxp3 and become induced Tregs, but when cultured 
with TGF-β and IL-6, the naive T cells generate Th17 
cells with pathological activities (osteoclastogenesis). 
Thus, when the immune response is not activated, TG-
F-β promotes the generation of induced Tregs that su-
ppress inflammation. However, when an infection is es-
tablished, for example, during the gingivitis or early sta-
ge of periodontitis, IL-6 is synthesized during the innate 
immune response by inhibiting the generation of Tregs 
and inducing the differentiation of Th17 cells that are 
pro-inflammatory and pro-resorptive in the presence of 
TGF-β (27). It is also known that the absence of Tregs, 
it is an indication for a great variety of disorders, such as 
autoimmunity, dermatitis, periodontitis and even trans-
plant rejection. A potential treatment option for these di-
sorders revolves around increasing the number of Tregs 
in local sites (28, 29).
This study demonstrated, prior to the nonsurgical 
periodontal therapy, an increase in TGF-β levels in the 
serum of patients with LAgP and GCP compared to con-
trols (Figure 2). This suggests a systemic effect of the 
disease, where TGF-β in periodontitis patients appears 
as a molecular component associated with the immu-
nosuppression of the inflammatory response, as TGF-β 
levels were higher in patients with LAgP and GCP than 
in the controls. IL-6 levels are not shown here in the re-
sults, since this cytokine was not detectable in the sam-
ples. Since the prevalence of LAgP is low (18, 30), the 
adopted grouping criterion also allowed the obtainment 
of a larger number of individuals with severe disease 
in the periodontitis group (Tables 1 and 2). However, 
the analysis of these individuals, also in periodontitis 
subgroups (LAgP, GAgP e GCP), becomes justified by 
previous studies (30-32) having shown a biological dis-
tinction in relation to systemic inflammatory markers 
between the AgP and CP.
WBC count is characterized as a crude marker of 
systemic inflammation and correlates to the host res-
ponse with respect to a variety of stimuli. This marker 
has also been associated with a significant prediction of 
future cardiovascular events and glucose intolerance in 
different populations (33, 34).
Figure 2. Serum levels of TGF-β pre and post-treatment. TGF-β - 
transforming growth factor beta.
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mission of the clinical signs of inflammation in the local 
sites of disease and significant improvements in the bio-
logical markers of inflammation in the peripheral blood 
requires efficient control of the formation of dental bio-
film which can only be monitored through rigorous SPT 
with frequent and individualized therapeutic interven-
tions for each patient in treatment and maintenance.
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